Effects of Electronic Cigarettes on Lung Biology
Sponsor: Weill Medical College of Cornell University
Terminated
Lack of funding
Other terminated trials from Weill Medical College of Cornell University
- Epilepsy · Apr 2025
- Anxiety Disorders · Phase NA · Nov 2024
- Myeloproliferative Neoplasm · Phase PHASE2 · Jul 2024
- Infertility, Male · Phase PHASE2 · May 2024
- Anxiety · Apr 2024
See all terminations from Weill Medical College of Cornell University
Listed as NCT02188511, this NA trial focuses on Lung Disease and Lung Disorder and remains terminated or withdrawn. Sponsored by Weill Medical College of Cornell University, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Aug 2020 — Jan 2021 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
May 2019 — Aug 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .